SC 13G: BIOVIE INC.

AI Summary

SC 13G filing by BIOVIE INC..

Risk Assessment

Risk Level: low

FAQ

Key Financial Figures

• $0.0001 — Name of Issuer) Class A Common Stock, $0.0001 par value per share (Title of Class o

Filing Documents

• g084509_sc13g.htm (SC 13G) — 87KB
• 0001753926-24-001767.txt ( ) — 89KB

(a)

Item 1(a). Name of Issuer: BioVie Inc. (the “ Issuer ”).

(b)

Item 1(b). Address of Issuer’s Principal Executive Offices: The Issuer’s principal executive offices are located at 680 W Nye Lane, Suite 201, Carson City, Nevada, 89703.

(a)

Item 2(a). Names of Persons Filing: This (i) 3i, LP, a Delaware limited partnership (“ 3i ”); (ii) 3i Management LLC, a Delaware limited liability company (“ 3i Management ”); and (iii) Maier Joshua Tarlow (“ Mr. Tarlow ”). The foregoing persons are hereinafter sometimes collectively referred to as the “ Reporting Persons ”. Any disclosures herein with respect to persons other than the Reporting Persons are made on information and belief after making inquiry to the appropriate party. The Reporting Persons have entered into a Joint Filing Agreement, a copy of which is filed as Exhibit 1 to this Schedule 13G, pursuant to which they have agreed to file this Schedule 13G and all subsequent amendments jointly in accordance with the provisions of Rule 13d-1(k) of the Act. The filing of this Schedule 13G should not be construed in and of itself as an admission by any Reporting Person as to beneficial

(b)

Item 2(b). Address of Principal Business Office or, if none, Residence: The principal business address of each of the Reporting Persons is 2 Wooster Street, 2 nd Floor, New York, NY 10013.

(c)

Item 2(c). Citizenship: 3i is a Delaware limited partnership. 3i Management is a Delaware limited liability company. Mr. Tarlow is a citizen of the United

(d)

Item 2(d). Title of Class of Securities: The title of the class of securities to which this statement relates is the Issuer’s shares of Class A common stock, $0.0001 par value per share (the “ Common Stock ”).

(e)

Item 2(e). CUSIP Number: 09074F405 Item 3. If This Statement is Filed Pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), Check Whether the Person Filing is a: Not applicable. CUSIP No. 09074F405 13G Page 6 of 9 Pages Item 4. The information required by this item with respect to each Reporting Person is set forth in Rows 5 through 9 and 11 of the cover pages to this Schedule 13G and is incorporated herein by reference for each such Reporting Person. The ownership percentages reported are based on (i) 16,612,374 shares of Common Stock outstanding, as disclosed in the prospectus supplement of the Issuer, dated October 23, 2024, to the registration statement on Form S-3 (File No. 333-274083), declared effective by the U.S. Securities and Exchange Commission on August 28, 2023, and (ii) 1,260,000 shares of Common Stock held by the Reporting Persons. As of the date of this Schedule 13G, the Reporting Persons hold (i) 1,260,000 shares of Common Stock, and (ii) common stock purchase warrants of the Issuer exercisable for up to 1,260,000 shares of Common Stock, which are not exercisable within 60 days of the date of this Schedule 13G. Consequently, 3i is the beneficial owner of 1,260,000 shares of Common Stock (the “ Shares ”). 3i has the power to dispose of and the power to vote the Shares beneficially owned by it, which power may be exercised by 3i Management, the manager and general partner of 3i. Mr. Tarlow, as the manager of 3i Management, has shared power to vote and/or dispose of the Shares beneficially owned by each of 3i and 3i Management. Mr. Tarlow does not directly own the Shares. By reason of the provisions of Rule 13d-3 of the Act, Mr. Tarlow may be deemed to beneficially own the Shares beneficially owned by 3i and 3i Management, and 3i Management may be deemed to beneficially own the Shares beneficially owned by 3i. Item 5. If this statement is being filed to r

View Full Filing

View this SC 13G filing on SEC EDGAR